Thomas Ertveldt

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck et al. · Journal of Nuclear Medicine · 2021 · 39 citations · Full text

Targeted α-Therapy Using²²⁵Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens et al. · Journal of Nuclear Medicine · 2023 · 25 citations · Full text

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma

Kim De Veirman, Janik Puttemans, Ahmet Krasniqi et al. · OncoImmunology · 2021 · 20 citations · Full text

Emerging applications of nanobodies in cancer therapy

Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens et al. · International review of cell and molecular biology · 2022 · 20 citations · Full text

Nanoparticles, Nanomedicine, Cancer Therapy +4

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy

Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt et al. · Pharmaceutics · 2023 · 20 citations · Full text

Cancer Therapy, Engineering, Immunology +20